Children hospitalized with breathing problems due to infection with respiratory syncytial virus (RSV) are likely to get sicker and remain hospitalized if they have high levels of defective copies of the virus, according to a new study by researchers at Washington University School of Medicine in St. Louis.
The 2020 Nobel Prize in Physiology or Medicine was awarded to three scientists for groundbreaking research that led to the discovery of the hepatitis C virus, an insidious and deadly blood-borne virus. One of those scientists – virologist Charles M. Rice, PhD – conducted his seminal work while on the faculty of Washington University School of Medicine.
School of Medicine researchers are establishing a new international collaboration that aims to help scientists prepare for the next pandemic and, perhaps, provide insight into the current one.
Researchers at Washington University in St. Louis have developed a COVID-19 vaccine candidate that has prevented pneumonia in mice.
To allow more labs to conduct coronavirus research, Whelan and a team of Washington University researchers devised a workaround: a genetically engineered virus.
A lab-created virus that’s similar to but not as dangerous as the new coronavirus could aid efforts to create COVID-19 treatments and vaccines, according to scientists who created it.
Researchers at Washington University School of Medicine have developed a hybrid coronavirus that will enable more scientists to enter the fight against the pandemic. The scientists genetically modified a mild virus by swapping one of its genes for one from SARS-CoV-2, the virus that causes COVID-19.
Washington University researchers are leading an effort to to find drugs to cure toxoplasmosis, a parasitic disease characterized by vision problems and brain complications.
Whelan, the Marvin A. Brennecke Distinguished Professor of Microbiology, studies how deadly viruses such as Ebola and rabies enter cells and multiply, a key step to finding targets for new antiviral drugs.